Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -1.67 Million USD | 32.62% |
| 2021 | -2.47 Million USD | -21.31% |
| 2020 | -2.04 Million USD | -2.18% |
| 2019 | -1.99 Million USD | -87.64% |
| 2018 | -1.06 Million USD | 79.36% |
| 2017 | -5.16 Million USD | -38.03% |
| 2016 | -3.74 Million USD | 34.77% |
| 2015 | -5.73 Million USD | -147.8% |
| 2014 | -2.31 Million USD | -17.87% |
| 2013 | -1.96 Million USD | 80.44% |
| 2012 | -10.04 Million USD | -1354.56% |
| 2011 | -690.35 Thousand USD | -396.4% |
| 2010 | -139.07 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -530.47 Thousand USD | -20.44% |
| 2023 Q1 | -440.45 Thousand USD | -265.04% |
| 2023 Q3 | -443.72 Thousand USD | 16.35% |
| 2022 Q4 | -120.65 Thousand USD | 76.3% |
| 2022 Q2 | -467.07 Thousand USD | 18.52% |
| 2022 Q3 | -509.15 Thousand USD | -9.01% |
| 2022 FY | -1.67 Million USD | 32.62% |
| 2022 Q1 | -573.24 Thousand USD | 48.25% |
| 2021 Q4 | -1.1 Million USD | -147.43% |
| 2021 Q1 | -523.62 Thousand USD | 28.68% |
| 2021 FY | -2.47 Million USD | -21.31% |
| 2021 Q2 | -399.78 Thousand USD | 23.65% |
| 2021 Q3 | -447.68 Thousand USD | -11.98% |
| 2020 Q4 | -734.16 Thousand USD | -35.71% |
| 2020 Q3 | -540.98 Thousand USD | -127.63% |
| 2020 Q2 | -237.65 Thousand USD | 55.21% |
| 2020 Q1 | -530.56 Thousand USD | -2888.42% |
| 2020 FY | -2.04 Million USD | -2.18% |
| 2019 Q3 | -505.48 Thousand USD | 26.78% |
| 2019 Q2 | -690.34 Thousand USD | 12.2% |
| 2019 FY | -1.99 Million USD | -87.64% |
| 2019 Q1 | -786.31 Thousand USD | -213.91% |
| 2019 Q4 | -17.75 Thousand USD | 96.49% |
| 2018 Q3 | -705.03 Thousand USD | -61.14% |
| 2018 Q2 | -437.51 Thousand USD | 28.68% |
| 2018 Q4 | 690.29 Thousand USD | 197.91% |
| 2018 Q1 | -613.48 Thousand USD | 78.19% |
| 2018 FY | -1.06 Million USD | 79.36% |
| 2017 Q3 | -546.63 Thousand USD | 25.09% |
| 2017 FY | -5.16 Million USD | -38.03% |
| 2017 Q4 | -2.81 Million USD | -414.59% |
| 2017 Q2 | -729.76 Thousand USD | 32.09% |
| 2017 Q1 | -1.07 Million USD | 23.69% |
| 2016 FY | -3.74 Million USD | 34.77% |
| 2016 Q4 | -1.4 Million USD | -89.83% |
| 2016 Q2 | -1.16 Million USD | -169.98% |
| 2016 Q1 | -430.03 Thousand USD | 86.2% |
| 2016 Q3 | -741.82 Thousand USD | 36.11% |
| 2015 FY | -5.73 Million USD | -147.8% |
| 2015 Q2 | -1.47 Million USD | -214.08% |
| 2015 Q3 | -1.05 Million USD | 28.66% |
| 2015 Q4 | -3.11 Million USD | -195.5% |
| 2015 Q1 | -470.71 Thousand USD | 49.55% |
| 2014 Q2 | -503.03 Thousand USD | -297.22% |
| 2014 FY | -2.31 Million USD | -17.87% |
| 2014 Q4 | -932.98 Thousand USD | -24.06% |
| 2014 Q3 | -752.02 Thousand USD | -49.5% |
| 2014 Q1 | -126.63 Thousand USD | 84.99% |
| 2013 Q4 | -843.66 Thousand USD | -107.6% |
| 2013 FY | -1.96 Million USD | 80.44% |
| 2013 Q1 | -511.08 Thousand USD | 94.41% |
| 2013 Q2 | -240.56 Thousand USD | 52.93% |
| 2013 Q3 | -406.38 Thousand USD | -68.93% |
| 2012 Q2 | -275.8 Thousand USD | 38.7% |
| 2012 Q1 | -449.9 Thousand USD | 31.72% |
| 2012 FY | -10.04 Million USD | -1354.56% |
| 2012 Q3 | -202.69 Thousand USD | 26.51% |
| 2012 Q4 | -9.15 Million USD | -4414.46% |
| 2011 Q2 | -8722.64 USD | -50.71% |
| 2011 Q3 | -10.51 Thousand USD | -20.53% |
| 2011 Q4 | -658.86 Thousand USD | -6166.74% |
| 2011 FY | -690.35 Thousand USD | -396.4% |
| 2011 Q1 | -5787.83 USD | 95.07% |
| 2010 FY | -139.07 Thousand USD | 0.0% |
| 2010 Q3 | -2833.33 USD | 84.4% |
| 2010 Q2 | -18.15 Thousand USD | 0.0% |
| 2010 Q4 | -117.3 Thousand USD | -4040.24% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AI/ML Innovations Inc. | -3.28 Million CAD | 49.157% |
| Diagnamed Holdings Corp. | -1.27 Million CAD | -30.69% |
| Pangenomic Health Inc. | -2.97 Million CAD | 43.822% |
| nDatalyze Corp. | -155.6 Thousand CAD | -973.342% |
| Treatment.Com International Inc. | -3.72 Million CAD | 55.133% |
| Unidoc Health Corp. | -2.25 Million CAD | 26.095% |